A standardized and validated approach to JAK2 VAF testing should be agreed and implemented, as has been successfully done for BCR-ABL1 in chronic myeloid leukemia. The gene discussed is JAK2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.